These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 32365480)

  • 1. The Role of Gut Dysbiosis in the Bone-Vascular Axis in Chronic Kidney Disease.
    Evenepoel P; Dejongh S; Verbeke K; Meijers B
    Toxins (Basel); 2020 Apr; 12(5):. PubMed ID: 32365480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interplay between gut microbiota, bone health and vascular calcification in chronic kidney disease.
    Rodrigues FG; Ormanji MS; Heilberg IP; Bakker SJL; de Borst MH
    Eur J Clin Invest; 2021 Sep; 51(9):e13588. PubMed ID: 33948936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of Gut Microbiota-Derived Uremic Toxins to the Cardiovascular System Mineralization.
    Filipska I; Winiarska A; Knysak M; Stompór T
    Toxins (Basel); 2021 Apr; 13(4):. PubMed ID: 33920096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin K deficiency: an emerging player in the pathogenesis of vascular calcification and an iatrogenic consequence of therapies in advanced renal disease.
    Levy DS; Grewal R; Le TH
    Am J Physiol Renal Physiol; 2020 Oct; 319(4):F618-F623. PubMed ID: 32830534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microbiota issue in CKD: how promising are gut-targeted approaches?
    Cosola C; Rocchetti MT; Sabatino A; Fiaccadori E; Di Iorio BR; Gesualdo L
    J Nephrol; 2019 Feb; 32(1):27-37. PubMed ID: 30069677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone-Vascular Axis in Chronic Kidney Disease.
    Evenepoel P; Opdebeeck B; David K; D'Haese PC
    Adv Chronic Kidney Dis; 2019 Nov; 26(6):472-483. PubMed ID: 31831125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Linking gut microbiota to cardiovascular disease and hypertension: Lessons from chronic kidney disease.
    Meijers B; Jouret F; Evenepoel P
    Pharmacol Res; 2018 Jul; 133():101-107. PubMed ID: 29715498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut microbiota and chronic kidney disease: evidences and mechanisms that mediate a new communication in the gastrointestinal-renal axis.
    Rukavina Mikusic NL; Kouyoumdzian NM; Choi MR
    Pflugers Arch; 2020 Mar; 472(3):303-320. PubMed ID: 32064574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic kidney disease and the gut microbiome.
    Hobby GP; Karaduta O; Dusio GF; Singh M; Zybailov BL; Arthur JM
    Am J Physiol Renal Physiol; 2019 Jun; 316(6):F1211-F1217. PubMed ID: 30864840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical impact of gut microbiota in chronic kidney disease.
    Kim SM; Song IH
    Korean J Intern Med; 2020 Nov; 35(6):1305-1316. PubMed ID: 32872729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microbiome modulation to correct uremic toxins and to preserve kidney functions.
    Caggiano G; Cosola C; Di Leo V; Gesualdo M; Gesualdo L
    Curr Opin Nephrol Hypertens; 2020 Jan; 29(1):49-56. PubMed ID: 31725010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intestinal Microbiota in Type 2 Diabetes and Chronic Kidney Disease.
    Sabatino A; Regolisti G; Cosola C; Gesualdo L; Fiaccadori E
    Curr Diab Rep; 2017 Mar; 17(3):16. PubMed ID: 28271466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current Therapy in CKD Patients Can Affect Vitamin K Status.
    Cozzolino M; Cianciolo G; Podestà MA; Ciceri P; Galassi A; Gasperoni L; Manna G
    Nutrients; 2020 May; 12(6):. PubMed ID: 32486167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microbiome and Cardiovascular Disease in CKD.
    Jovanovich A; Isakova T; Stubbs J
    Clin J Am Soc Nephrol; 2018 Oct; 13(10):1598-1604. PubMed ID: 29743160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysbiosis in Patients with Chronic Kidney Disease: Let Us Talk About Vitamin K.
    Kemp JA; Alvarenga L; Cardozo LFMF; Dai L; Stenvinkel P; Shiels PG; Hackeng TM; Schurgers LJ; Mafra D
    Curr Nutr Rep; 2022 Dec; 11(4):765-779. PubMed ID: 36138326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pathomechanism and treatment of gut microbiota dysbiosis in chronic kidney disease and interventional effects of Chinese herbal medicine].
    Han WB; Liu YL; Wan YG; Sun W; Tu Y; Yang JJ; Wu W; He WM; Yao J
    Zhongguo Zhong Yao Za Zhi; 2017 Jul; 42(13):2425-2432. PubMed ID: 28840678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of the Gut Microbiome on Chronic Kidney Disease.
    Sampaio-Maia B; Simões-Silva L; Pestana M; Araujo R; Soares-Silva IJ
    Adv Appl Microbiol; 2016; 96():65-94. PubMed ID: 27565581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The crosstalk of gut microbiota and chronic kidney disease: role of inflammation, proteinuria, hypertension, and diabetes mellitus.
    Kanbay M; Onal EM; Afsar B; Dagel T; Yerlikaya A; Covic A; Vaziri ND
    Int Urol Nephrol; 2018 Aug; 50(8):1453-1466. PubMed ID: 29728993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut microbiome in chronic kidney disease: challenges and opportunities.
    Nallu A; Sharma S; Ramezani A; Muralidharan J; Raj D
    Transl Res; 2017 Jan; 179():24-37. PubMed ID: 27187743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The gut-liver-kidney axis: Novel regulator of fatty liver associated chronic kidney disease.
    Raj D; Tomar B; Lahiri A; Mulay SR
    Pharmacol Res; 2020 Feb; 152():104617. PubMed ID: 31881272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.